TrialFrontiers in immunology2023

The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial.

Qian Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.